Do Antibiotics Prevent Anal Fistulae Formation?
This study has been completed.
Sponsor:
Ankara University
Information provided by:
Ankara University
ClinicalTrials.gov Identifier:
NCT01012843
First received: November 12, 2009
Last updated: November 13, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Purpose: This randomized study assesses the effects of antibiotics on the formation of fistulae after drainage of anorectal abscesses.
Methods: Patients who underwent abscess drainage in 3 major colorectal units between September 2005 and January 2008 were included. Previous anorectal surgery history, immunecompromised states, pregnancy, inflammatory bowel disease, antibiotic usage prior to surgery and the presence of an anal fistulae at the time of surgery were the exclusion criteria. Patients were randomized and given either placebo or amoxicillin-clavulanic acid combination treatment for 10 days. Patients were followed one year for perianal fistulae formation.
| Condition | Intervention |
|---|---|
|
Anal Fistula |
Drug: Amoxicillin-Clavulanate Drug: Placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver) Primary Purpose: Prevention |
| Official Title: | Does Adjuvant Antibiotic Treatment After Drainage of Anorectal Abscess Prevent the Development of Anal Fistulae? A Prospective Randomized, Placebo Controlled, Double Blind, Multi-Center Clinical Study |
Resource links provided by NLM:
Further study details as provided by Ankara University:
Primary Outcome Measures:
- Fistula formation [ Time Frame: 1 year after surgery ] [ Designated as safety issue: No ]
| Enrollment: | 151 |
| Study Start Date: | September 2005 |
| Study Completion Date: | January 2008 |
| Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Antibiotic
Patients who received antibiotic treatment after abscess drainage
|
Drug: Amoxicillin-Clavulanate
oral 875/125 mg tablets of Amoxicillin/Clavulanate 2 times a day for 10 days
Other Name: Bioment 1 gr BID tablets
|
|
Placebo Comparator: Placebo
Patients who received placebo after abscess drainage
|
Drug: Placebo
oral Placebo tablets two times a day for 10 days
Other Name: Placebo
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Presence of anorectal abscess
Exclusion Criteria:
- Allergy to penicillin derivatives
- Treatment with any antimicrobial agent in the week before enrolment
- Recognized other infection at the time of surgery
- Previous anorectal surgery
- Presence of inflammatory bowel disease
- Suspicion of Fournier's gangrene
- Secondary and recurrent anorectal abscesses
- Presence of an internal opening
- Any additional surgical procedure performed in the same session or during follow-up
- Antibiotic prophylaxis indicated for another reason
- Immunosuppressive and/or anticoagulant drug treatment being taken at the time of surgery
- Diabetes mellitus
- Known chronic disabling disease
- Pregnancy
- Lactation.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01012843
Locations
| Turkey | |
| Ankara University School of Medicine Department Of General Surgery | |
| Ankara, Turkey, 06100 | |
| Ankara Numune Teaching and Research Hospital | |
| Ankara, Turkey, 06100 | |
| Dicle University School of Medicine | |
| Diyarbakir, Turkey | |
Sponsors and Collaborators
Ankara University
Investigators
| Study Chair: | Ulas Sozener, M.D. | Ankara University School of Medicine |
More Information
Publications:
| Responsible Party: | Dr. Ulas Sozener, Ankara University School of Medicine Department of General Surgery |
| ClinicalTrials.gov Identifier: | NCT01012843 History of Changes |
| Other Study ID Numbers: | AUTF-001 |
| Study First Received: | November 12, 2009 |
| Last Updated: | November 13, 2009 |
| Health Authority: | Turkey: Ethics Committee Turkey: Ministry of Health |
Keywords provided by Ankara University:
|
Perianal Abscess Fistulae in ano Antibiotic Anorectal |
Additional relevant MeSH terms:
|
Fistula Rectal Fistula Pathological Conditions, Anatomical Intestinal Fistula Digestive System Fistula Digestive System Diseases Intestinal Diseases Gastrointestinal Diseases Rectal Diseases Amoxicillin |
Anti-Bacterial Agents Amoxicillin-Potassium Clavulanate Combination Clavulanic Acids Clavulanic Acid Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |
ClinicalTrials.gov processed this record on June 18, 2013